Glaucoma 360: Eyedrop targets and reduces episcleral venous pressure in glaucoma
February 8th 2023Thurein Htoo, MS, MBA, CEO and co-founder of Qlaris Bio, took the podium at the New Horizons Forum at the Glaucoma 360 conference in San Francisco to discuss the performance of the company’s episcleral venous pressure eyedrop, QLS-111.
Identifying herpesvirus DNA in corneal grafts
January 10th 2023Recent research suggests the need for routine HSV-1 and VZV PCR testing in all explanted corneas regardless of clinical suspicion to detect, treat, and prevent possible recurrence of herpes infection in corneal grafts and support graft survival.
Why patients with inflammatory bowel disease might need to see their ophthalmologist
January 4th 2023Ocular involvement in IBD is a rare extraintestinal manifestation, but may be critical because of its potential sight-threatening complications if not treated promptly and accurately, according to researchers.
Imaging shows ocular changes in chronic thromboembolic pulmonary hypertension
January 2nd 2023The research team reported a few differences in patients that included a decreased mean vessel density at the deep vascular complex of the macula, a decreased mean subfoveal choroidal thickness, and an increase in the size of the foveal avascular zone.